64 research outputs found

    Lessons learned from CHIPPS (Care Homes Independent Pharmacist Prescribing Study): How feasibility studies informed ultimate randomised controlled trial design

    Get PDF
    The use of medicines in care homes could be improved and as a result, the health of residents would be better. Pharmacist prescribers (i.e. pharmacists specifically trained and qualified to prescribe), have been shown to provide safe, quality care in other patient groups. We proposed to test if making ā€˜pharmacist prescribersā€™ part of the care home team, working alongside general practitioners, could improve the use of medicines and the care of residents. These pharmacist prescribers authorised monthly prescriptions whilst carefully monitoring how each resident responded. We believe that such a change to the management of medicines in care homes is likely to be a good use of NHS money. This paper describes a series of developmental studies that were undertaken as part of a programme of work which followed the MRC Framework for developing and evaluating a complex intervention. The rationale for each study is described and for the final of these feasibility studies, when all components were tested together, we consider what went well, some of the challenges we encountered, and how they informed our decision to progress to a definitive randomised controlled trial

    Pharmacist prescribing in the United Kingdom and the implication for the Nigerian context

    Get PDF
    Background: Non-medical professionals including pharmacists have been granted the right to prescribe medicines in the United Kingdom. In Nigeria, only medical doctors, dentists and some nurses in primary care facilities have the legal right to prescribe medicines and patients' access to prescriptions can be seriously affected by a shortageof prescribers and long waiting times in hospitals. Objective: This article presents a review of pharmacist prescribing in the UK including its model, impact, facilitators and barriers and discusses the implications for the Nigerian context. Methods: A literature search was conducted in Medline, Embase, International Pharmaceutical Abstracts and Cumulative Index to Nursing and Allied Health Literature databases for studies investigating pharmacist prescribing in the UK between 1990 and August 2013. Results: The review identified that legislative change in the UK has enabled pharmacists to prescribe first as supplementary prescribers then as independent prescribers. This policy change was driven by the desire to increase patients' access to medicines and promote the utilisation of the skills of non-medical professionals while maintaining patient safety. Although more robust research evidence is needed to demonstrate the effectiveness of pharmacist prescribing, available evidence shows that it has had an impact on patient access to medicines. Conclusion: Pharmacist prescribing has the potential to promote access to prescription medicines, free doctors' time to enable them deal with complex cases and promote efficient use of pharmacists' clinical skills in Nigeria as it does in the UK. Factors which can promote the extension of prescribing rights to pharmacists in Nigeria include the current level of pharmacists' training and the clinical roles of pharmacists in some tertiary hospitals

    Enhancing deprescribing : a qualitative understanding of the complexities of pharmacist-led deprescribing in care homes

    Get PDF
    Funding statement This research is funded by the National Institute for Health Research (NIHR) Policy Research Programme (project reference NIHR202053). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Acknowledgements Thank you to the pharmacists, GP practice and care home staff who took part in the interviews. We would also like to acknowledge the Norfolk and Waveney Clinical Commissioning Group as the study sponsor and our patient and public involvement colleagues Janet Gray and Christine Hanford who were supported by Jacqueline Romero, manager of PPIRes.Peer reviewedPublisher PD

    Pharmacist-independent prescriber deprescribing in UK care homes : Contextual factors associated with increased activity

    Get PDF
    ACKNOWLEDGEMENTS We would like to thank the residents, families, pharmacists, medical practice staff and care home staff who contributed to CHIPPS. Funding information: This study is funded by the National Institute for Health Research (NIHR) for Health Research (NIHR) Translating Research into Policy funding scheme (Award ID: NIHR202053). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.Peer reviewedPublisher PD

    'Treated as a number, not treated as a person': a qualitative exploration of the perceived barriers to effective pain management of patients with chronic pain

    Get PDF
    Open Access articleObjectives To identify barriers to effective pain management encountered by patients with chronic pain within the UKā€™s National Health Service (NHS). Design Secondary analysis of face-to-face, semistructured qualitative interviews using thematic analysis. Setting A community-based chronic pain clinic jointly managed by a nurse and pharmacist located in the North of England. Participants Nineteen adult (>18 years) patients with chronic pain discharged from a pain clinic, with the ability to understand and speak the English language. Results In general, patients were highly disappointed with the quality of pain management services provided both within primary and secondary care, and consequently were willing to seek private medical care. Barriers to effective pain management were divided into two main themes: healthcare professional-related and health systems-related. Three sub-themes emerged under healthcare professionals-related barriers, namely (1) healthcare professionalsā€™ lack of interest and empathy, (2) general practitionersā€™ (GP) lack of specialised knowledge in pain management and (3) lack of communication between healthcare professionals. Three subthemes emerged under health system-related barriers: (1) long waiting time for appointments in secondary care, (2) short consultation times with GPs and (3) lack of an integrated multidisciplinary approach. Conclusions The patients expressed a clear desire for the improved provision and quality of chronic pain management services within the NHS to overcome barriers identified in this study. An integrated holistic approach based on a biopsychosocial model is required to effectively manage pain and improve patient satisfaction. Future research should explore the feasibility, effectiveness and cost-effectiveness of integrated care delivery models for chronic pain management within primary car

    Evaluation of a training programme for Pharmacist Independent Prescribers in a care home medicine management intervention

    Get PDF
    Background: The provision of independent prescribing rights for United Kingdom (UK) pharmacists has enabled them to prescribe within their area of competence. The aim of this study was to evaluate an evidence-based training programme designed to prepare Pharmacist Independent Prescribers (PIPs) to safely and effectively assume responsibility for pharmaceutical care of older people in care homes in the UK, within a randomised controlled trial. Methods: The training and competency assessment process included two training days, professional development planning against a bespoke competency framework, mentor support, and a viva with an independent General Practitioner (GP). Data on the PIPsā€™ perceptions of the training were collected through evaluation forms immediately after the training days and through online questionnaires and interviews after delivery of the 6-month intervention. Using a mixed method approach each data set was analysed separately then triangulated providing a detailed evaluation of the process. Kaufmanā€™s Model of Learning Evaluation guided interpretations. Results: All 25 PIPs who received the training completed an evaluation form (N=25). Post-intervention questionnaires were completed by 16 PIPs and 14 PIPs took part in interviews. PIPs reported the training days and mentorship enabled them to develop a personalised portfolio of competence in preparation for discussion during a viva with an independent GP. Contact with the mentor reduced as PIPs gained confidence in their role. PIPs applied their new learning throughout the delivery of the intervention leading to perceived improvements in residentsā€™ quality of life and medicines management. A few PIPs reported that developing a portfolio of competence was time intensive, and that further training on leadership skills would have been beneficial. Conclusions: The bespoke training programme was fit for purpose. Mentorship and competency assessment were resource intensive but appropriate. An additional benefit was that many PIPs reported professional growth beyond the requirement of the study

    Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes : cluster randomised controlled trial

    Get PDF
    Acknowledgments We thank all participating care home residents, care homes, and general practices; the pharmacist independent prescribers; our patient and public involvement group; our pharmacist trainers and assessors; Norwich Clinical Trials Unit; Comprehensive Research Network Eastern; our sponsor (Norfolk and Waveney CCG); members of our Programme Steering Committee and Data Monitoring and Ethics Committee; our funders; and all the many other people who supported the delivery of the programme of research that culminated in this trial. Funding: This work was funded by National Institutes of Health Research (NIHR) through their Programme Grant for Applied Research (PGfAR) stream (RP-PG-0613-20007). The funder had no role in design, data collection, data analysis, data interpretation, or writing of this paper.Peer reviewedPublisher PD
    • ā€¦
    corecore